Aspirin and painkillers such as ibuprofen have been deemed too risky for use in the prevention of colon cancer, according to a federal task force.

The risk of intestinal bleeding, stroke, kidney failure, and other health problems led the US Preventative Services Task Force to conclude that taking more than 300 milligrams per day of drugs like Motrin, Advil, and Aleve is just too risky to outweigh the potential benefits of preventing cancer. And while taking less than 100 milligrams of such drugs can reduce the risk of heart disease, it does nothing to lower the rate of colon cancer.

Details about this task force study are published in Monday's issue of the Annals of Internal Medicine.

Cancer patients who have heart attacks are typically not treated with a course of life-saving aspirin because of the belief that these patients might experience lethal bleeding.

This belief is now under dispute and researchers at The University of Texas M. D. Anderson Cancer Center say that without aspirin, the majority of these patients will die. Their arguments, subject of a recent study, will be published in the February 1 issue of the journal Cancer.

Aspirin has been viewed as harmful because of its tendency to thin blood. Because cancer patients can experience low platelet counts and abnormal clotting, aspirin has been considered a contraindication. But this study found that nine of 10 cancer patients with low platelet counts who experienced heart attacks and who did not receive aspirin died. Only one patient died, however, in a group of 17 cancer patients who received aspirin.

This conclusion -- that aspirin helps people with cancer just as it does for people without cancer -- may help medical professionals determine guidelines for treatment of heart attacks in cancer patients. Because right now, physicians are uncertain about how to balance treatment for both conditions.

Aspirin, and other nonsteroidal anti-inflammatory drugs (NSAIDs), are known to halt the growth of some cancers, such as colorectal cancer, breast cancer and ovarian cancer, but no one could really explain why. Obviously, as a result it was believed that chronic inflammation might be leading to increased cancer risks. Still, no one could explain how any of this was happening enough to harness the ability to replicate it.

Beth Israel Deaconess Medical Center and Columbia University Medical Center researchers have announced the discovery of a novel tumor suppressor gene that works with NSAIDS to stop the growth of cancer cells.

"Current clinical trials are evaluating a range of NSAIDs for a variety of cancers without any clear vision of the best way to use them," states Towia Libermann, PhD, Director of the BIDMC Genomics Center and Associate Professor of Medicine at Harvard Medical School. "The fact that upregulation of this single gene MDA-7/IL-24 -- correlated not only with cell death induction of numerous types of cancer but also among various diverse classes of NSAIDs, makes this discovery particularly exciting."

As a result of this discovery, researchers believe newer targeted cancer therapies can be developed. To read more about the discovery, visit Beth Israel Deaconess Medical Center and Columbia University Medical Center's Study Explains How NSAIDs Halt Cancer Growth.

Some of the previous posts we have on inflammation, cancer and aspirin are:

• Aspirin: amazing wonder drug in fighting cancer
• Inflammation link between rheumatoid arthritis and cancer
• What aspirin reveals about cancer

The National Cancer institute reports that about two to five percent of all malignancies diagnosed in the United States are head and neck cancers. About 39,000 new cases are diagnosed each year. In a long term study aspirin use taken over a long duration cut the risk of head and neck cancer by 30 percent. It wasn't so much the amount of aspirin that was taken but the length of time that people were on the drug that mattered.

Aspirin is a non-steroidal anti-inflammatory drug (NSAIDS). Experts believe that aspirin could be a cancer preventing medication but more studies need to be conducted to see if the rewards outweigh the risks of taking aspirin on a daily basis. There is a chance of gastrointestinal bleeding associated with daily use and it is not recommended that anyone start on an aspirin regime without discussing it with his or her physician first.

Simple every day aspirin has long been called a wonder drug, and the wonders of aspirin cease to amaze. The ability of aspirin to effectively fight cancer is a known, according to researchers. In What aspirin reveals about cancer, we posted "Aspirin may reduce the risks from a number of cancers. Why? Medical researchers from different fields of study are coming together on a common thread of evidence suggesting that inflammation in the body may be at the core of many diseases, including cancer."

When we brought you that information, researchers knew the anti-cancer effect of aspirin was tied in to aspirin being an anti-inflammatory but beyond that, the mechanism behind how aspirin worked against cancer was an unknown.

Recently, University of Newcastle scientists have made a new discovery of how aspirin fights cancer. Aspirin appears to cut off the blood supply to a developing cancer tumor. Without a needed blood supply, the tumor has difficulty continuing to grow. High doses of aspirin were used in the study, and high doses of aspirin are not recommended, as the side effects of stomach bleeding can occur. According to the researchers, the normal dose of aspirin did not affect cancer cells, but seemed to disrupt the surrounding proteins that provide a support structure for blood vessels.

While it is not take two aspirin and call me in the morning, the study does show promise in the possibility of new cancer treatments.

This study is published in the October 2006 issue of The Federation of American Societies for Experimental Biology (FASEB) Journal.

No one is suggesting that men start taking aspirin for prostate health if they are not already taking aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs) for other reasons. However, Mayo Clinic researchers do say that men who are already taking a daily dose of aspirin might be enjoying a better level of prostate health. According to researchers, aspirin seems to prevent or delay an enlarged prostate that can lead to urinary difficulties such as frequent urination, trouble urinating, weak urine stream and an urgent need to urinate.

While the researchers cannot state why NSAIDs benefit prostate health for benign prostatic hyperplasia, previous research has indicated aspirin provides certain prostate cancer prevention benefits. Many older adults already take aspirin, or other NSAIDs, for heart health and arthritis, and taking aspirin now appears to offer another added benefit in prostate health for men. Aspirin is not without its downside. Researchers do warn that taking aspirin can lead to stomach ulcers. As with any drug, one has to weigh the risk against the benefit.

According to former U.S. Surgeon General David Satcher, M.D., Ph.D., "Currently, about 95 percent of health care dollars in the United States are spent on treating diseases, with relatively little attention paid to preventing diseases, which should be a national priority."

As a result, Partnership for Prevention has released a report, Priorities for America's Health, that ranks the top 25 preventive health services that are most effective. Of the top 25, ten are related to cancer. Following is a list of the top ten ways to practice cancer prevention.

Aspirin may reduce the risks from a number of cancers. Why? Medical researchers from different fields of study are coming together on a common thread of evidence suggesting that inflammation in the body may be at the core of many diseases, including cancer. The body is an amazing and intelligently complex system, ever busy, in a mysterious mechanism invisible to our every day consciousness.

A simple splinter lodged in the finger sets off a course of action any seasoned military field general would find admirable. Mast cells send a signal, alerting the body there is an invader, blood vessels begin developing leaks to allow immune cells to engage the enemy in battle, and before the main immune cell troops arrive, pre-stationed front line troops begin attacking the invader with toxic chemicals. The specialized trained-to-destroy immune cells arrive, surrounding the enemy, defeating the invaders and halting the invasion. Another signal is sent, declaring victory, and the medic cells are sent to repair the damage done during the battle. Balance is restored at the perimeters of the homeland, all is quiet on the battlefront, all cells resume their designated positions. To wait again, for the next invader.

Disease seems to happen as a result of friendly fire, when the troops become confused, and believing there is an invasion when none exists, begin attacking enemies where there are none. Or the invasion is a continuous one, resulting from a chronic infection created by a steady stream of toxins entering the body from outside sources, or internally, as can happen with untreated gum disease. The troops eventually become exhausted, unable to fight on. The worst case, is when troops abandon their posts, and there is no one left to fight the battle. Researchers are finding aspirin, and aspirin-like compounds, may halt the battle before it begins. Aspirin certainly will provide a direction researchers can investigate in understanding the genesis and progression of disease.

TIME: How Inflammation Works provides an online slide show graphically illustrating the body response to inflammation.